These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 4138226

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The ocular risks of treatment of Basedow's disease (author's transl)].
    Mornex R, Pousset G, Guinet P.
    Ann Endocrinol (Paris); 1974; 35(1):74-8. PubMed ID: 4138066
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Basedow's disease. Individual therapy of is great significance].
    Hörmann R.
    MMW Fortschr Med; 2005 Sep 01; 147(35-36):47. PubMed ID: 16180573
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Basedow's disease: surgery, the choice treatment].
    Chiampo L.
    Minerva Endocrinol; 1987 Sep 01; 12(1):49-53. PubMed ID: 2438548
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A, Janicki K, Pietura R, Janicka L.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Sep 01; 58(1):248-53. PubMed ID: 15314994
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of Basedow's disease by long-term administration of synthetic antithyroid drugs associated with small doses of I-131 prescribed without dosimetry. Apropos of 293 cases with a follow-up of 12 years].
    Jaffiol C, Baldet L, Robin M, Papachristou C, Mirouze J, Lapinski H.
    Ann Endocrinol (Paris); 1974 Sep 01; 35(1):34-5. PubMed ID: 4138155
    [No Abstract] [Full Text] [Related]

  • 12. [Hyperthyreosis in Basedow's disease].
    Välimäki MJ.
    Duodecim; 1998 Sep 01; 114(5):447-54. PubMed ID: 11466937
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Basedow's disease: medical treatment].
    Gnudi A.
    Minerva Endocrinol; 1987 Sep 01; 12(1):45-7. PubMed ID: 3587200
    [No Abstract] [Full Text] [Related]

  • 15. [Surgical treatment of Basedow's disease. Review of a series of 823 operations (author's transl)].
    Blondeau P, Wolfeler L, Rene L.
    Ann Chir; 1978 Dec 01; 32(10):779-87. PubMed ID: 86322
    [No Abstract] [Full Text] [Related]

  • 16. Preventing Graves' ophthalmopathy.
    Wiersinga WM.
    N Engl J Med; 1998 Jan 08; 338(2):121-2. PubMed ID: 9420345
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Controversies in the management of Graves' disease.
    Leech NJ, Dayan CM.
    Clin Endocrinol (Oxf); 1998 Sep 08; 49(3):273-80. PubMed ID: 9861313
    [No Abstract] [Full Text] [Related]

  • 19. Hyperthyroidism.
    Helling TJ.
    Lancet; 2003 Nov 08; 362(9395):1584-5. PubMed ID: 14615127
    [No Abstract] [Full Text] [Related]

  • 20. [Developmental analysis of 165 cases of Basedow's disease treated with low doses of I-131 associated with synthetic antithyroid drugs in long-term treatment].
    Jaffiol C, Baldet L, Ghachem M, Mirouze J.
    Ann Endocrinol (Paris); 1972 Nov 08; 33(2):148-50. PubMed ID: 4118100
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.